Table 3.
Recommendation of Vaccinations Before and After the Pandemic
| Before COVID-19 Pandemic | After COVID-19 Pandemic | p | |
|---|---|---|---|
| n(%) | n(%) | ||
| Influenza | 383 (88.0) | 354 (81.4) | <0.001 |
| PCV13 | 341 (78.4) | 328 (75.4) | 0.131 |
| PPSV23 | 210 (48.3) | 189 (43.4) | 0.016 |
| RZV | 39 (9.0) | 15 (3.4) | <0.001 |
| Tdap or Td | 102 (23.4) | 57 (13.1) | <0.001 |
Note: Bold values indicates statistical significance (p < 0.05).
Abbreviations: PCV13, Conjugated Pneumococcal; PPSV23, Pneumococcal polysaccharide; RZV, Zoster recombinant; Tdap or Td, Tetanus, diphtheria, pertussis.